Ratiopharm owners secure loan but are forced to sell
This article was originally published in Scrip
Executive Summary
VEM Vermögensverwaltung, the German investment unit headed by the Merckle family, has secured a bridging loan with its creditor banks, but is being forced to sell the generics firmRatiopharm. The sale will be overseen by the management of the company and a trustee to be decided by VEM and the banks.